MyFinsight
Home
Blog
About
Income Statement
|
Cash Flow
|
Balance Sheet
|
Ratios
Income Overview
Net Income
$78,156K
EPS
$1.84
Unit: Thousand (K) dollars
Subscribe for Financial Insights
Page 1
Quarterly
123
Page 1
Income Statement
2026-06-30
2026-03-31
2025-12-31
2025-09-30
Revenues
-
-
2,000*
-
Cost of revenue
-
-
1,987*
-
Gross profit
-
-
13*
-
Research and development expenses
-
1,594
3,101*
1,153
General and administrative expenses
2,766
2,065
4,627*
1,274
Operating loss
-2,766
-3,659
-7,714*
-2,427
Other income, net
610
8,250
-39*
408
Financial income, net
103,743
44,849
-25,799*
61,470
Income before tax expenses
101,587
49,440
-33,553*
59,451
Tax benefit (expenses)
23,431
11,130
-5,096*
11,062
Net income
78,156
-
-28,457*
48,389
Non-controlling interests
-
-
17*
-6
Companys stockholders
78,156
38,310
-28,474
48,395
Basic EPS
1.9
0.94
-0.699
1.16
Diluted EPS
1.84
0.91
-0.68
1.13
Basic Average Shares
41,040,479
40,773,866
40,709,204
41,756,301
Diluted Average Shares
42,501,252
41,970,186
41,872,003
42,774,504
Page 1
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.
Page 1
Buy us a coffee
Time Plot
Show the time plot by selecting a row from the table.
Income Statement
Financial income, net
$103,743K
(575.15%↑ Y/Y)
Other income, net
$610K
(137.35%↑ Y/Y)
Income before tax
expenses
$101,587K
(673.47%↑ Y/Y)
Operating loss
-$2,766K
(-11.13%↓ Y/Y)
Net income
$78,156K
(489.41%↑ Y/Y)
Tax benefit
(expenses)
$23,431K
(18696.03%↑ Y/Y)
General and
administrative expenses
$2,766K
(90.10%↑ Y/Y)
Companys stockholders
$78,156K
(488.17%↑ Y/Y)
Buy us a coffee
ORAMED PHARMACEUTICALS INC. (ORMP)
ORAMED PHARMACEUTICALS INC. (ORMP)